9IC9

X-ray structure of the drug binding domain of AlbA in complex with the KMR-04-165 compound of the pyrrolobenzodiazepines class

This is a non-PDB format compatible entry.

Summary for 9IC9

• Entry DOI: 10.2210/pdb9ic9/pdb
• Descriptor: Albicidin resistance protein, 4-[4-[4-[[(6R,6aS)-2-methoxy-6-oxidanyl-11-oxidanylidene-5,6,6a,7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]phenyl]-1-methyl-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrrole-2-carboxamide, 4-[4-[4-[[(6S,6aS)-2-methoxy-6-oxidanyl-11-oxidanylidene-5,6,6a,7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]phenyl]-1-methyl-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrrole-2-carboxamide, ... (5 entities in total)
• Functional Keywords: drug binding, bacterial resistance, pyrrolobenzodiazepines, dna binding protein, antimicrobial protein
• Biological source: Klebsiella oxytoca
• Total number of polymer chains: 1
• Total formula weight: 27711.29

Authors

Di Palma, M.,Steiner, R.A. (deposition date: 2025-02-14, release date: 2026-03-04)

• Primary citation: Di Palma, M.,Steiner, R.A.; X-ray structure of the drug binding domain of AlbA in complex with the KMR-04-165 compound of the pyrrolobenzodiazepines class; To Be Published,

Experimental method

X-RAY DIFFRACTION (1.6 Å)